Intensity Therapeutics, Inc. (INTS)
NASDAQ: INTS · Real-Time Price · USD
4.050
-0.280 (-6.47%)
Jul 30, 2026, 4:00 PM EDT - Market closed
Intensity Therapeutics Market Cap
Intensity Therapeutics has a market cap or net worth of $10.95 million as of July 30, 2026. Its market cap has increased by 36.01% in one year.
Market Cap
10.95M
Enterprise Value
803.42K
1-Year Change
36.01%
Ranking
Category
Stock Price
$4.05
ChartMarket Cap Chart
Since the IPO on June 30, 2023, Intensity Therapeutics's market cap has decreased from $66.01M to $10.95M, a decrease of -83.42%. That is a compound annual growth rate of -44.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2026 | 10.95M | -55.57% |
| Dec 31, 2025 | 24.64M | -7.32% |
| Dec 31, 2024 | 26.58M | -77.37% |
| Dec 29, 2023 | 117.49M | 77.98% |
| Jun 30, 2023 | 66.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lisata Therapeutics | 13.11M |
| Lexaria Bioscience | 12.93M |
| BioLineRx | 12.86M |
| Cocrystal Pharma | 12.67M |
| KALA BIO | 12.47M |
| Phio Pharmaceuticals | 12.20M |
| GT Biopharma | 12.05M |
| IN8bio | 11.72M |